TeqDr

What TeqDr does

TeqDr is a UK-based healthcare service company that provides ECG (electrocardiogram) interpretation and wearable device ECG data analysis for healthcare professionals. The company is headquartered in London and operates as a private, for-profit entity with a small team of 1-10 employees. Its primary customer segment is healthcare providers, specifically medical professionals and healthcare institutions in the United Kingdom requiring access to trusted ECG interpretation services.

The product portfolio centers on the TeqDr ECG Interpretation Service, a core offering that delivers ECG interpretation to clinical users, supplemented by a sub-product called Cardio Bridge. The underlying core technology is ECG interpretation technology, though specific proprietary features, algorithmic approaches, or platform architecture are not disclosed in the available source material. The distribution model is a web-based service platform accessed via self-serve/PLG mechanics, with a blog operated as a top-of-funnel content marketing channel.

Pricing is not publicly disclosed, and no revenue figures, funding rounds, partnerships, certifications, or management team details are available in the input. The company operates exclusively in the United Kingdom, with no signals of geographic expansion beyond a single-country, domestic scope. Information on the specific mechanics of how reports are generated, turnaround times, clinician credentials, or quality assurance frameworks is absent from the source data.

Name

TeqDr

Legal name

TeqDr

Website

https://teqdr.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

TeqDr is a UK-based healthcare service providing ECG interpretation and wearable device ECG data analysis to medical professionals and healthcare providers in the United Kingdom, delivered via a web-based platform.

Ownership category

akta.pro rank

Product category

Cardiac Diagnostics Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Cardiology Telemedicine Platforms (HLALAGAB)

akta.pro secondary industries

Diagnostic & Triage Decision Support (HLACAGAA), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• ECG interpretation services
• Wearable ECG analysis
• Cardiac diagnostics
• Healthcare ECG reporting
• Remote cardiac monitoring

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels1 record

Core offering

TeqDr provides ECG (electrocardiogram) interpretation services for healthcare professionals and healthcare providers in the United Kingdom. The service extends to analysis of ECG data captured by wearable devices, supporting medical professionals who need trusted cardiac trace interpretation.

Product overview

TeqDr is a UK-based healthcare technology company offering ECG interpretation services. The company provides its core ECG interpretation service to medical professionals, with Cardio Bridge appearing to be a related product offering. The product portfolio consists of a primary ECG interpretation service and at least one additional product under the Cardio Bridge name, though the specific architecture and relationship between these offerings is not detailed in the available sources.

Differentiator

Problem solved

Functional benefit

Products and services

• TeqDr ECG Interpretation Service Core ECG (electrocardiogram) interpretation service delivered to medical professionals and healthcare providers in the UK, including analysis of ECG data captured from wearable cardiac devices.
• Cardio Bridge Cardio Bridge is a related product/service offered by TeqDr under its ECG interpretation portfolio; specific capabilities and target users are not detailed in the available source material.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights2 records

Emerging players

• Cardio Diagnostics: Cardio Diagnostics provides AI-driven epigenetic and cardiac diagnostics, including ECG-based risk assessment. Comparable as an emerging cardiac diagnostics company selling clinician-facing interpretation, though focused on a different test modality.
• B-Secur: B-Secur applies AI to ECG signal analysis, offering ECG-based biometrics and cardiac health insights. Comparable in applying algorithmic ECG analysis for clinical use cases, though with a stronger technology/IP orientation than TeqDr.

Direct peers

• Heartbeam: Heartbeam develops credit-card-sized ECG devices paired with a clinician interpretation service, comparable in bundling wearable/portable ECG capture with a remote reading service for medical professionals.
• iRhythm Technologies: iRhythm's Zio service provides ambulatory ECG monitoring with centralized clinician interpretation, closely mirroring TeqDr's model of outsourced ECG reading for healthcare providers, but at a much larger US-scale, publicly-traded operation.
• Cardiomatics: Cardiomatics provides AI-powered ECG analysis as a service to cardiologists and clinics, very comparable to TeqDr's offering of ECG interpretation to healthcare providers, with similar early-stage, B2B clinician focus.
• Powerful Medical (PMcardio): Powerful Medical offers PMcardio, an AI ECG interpretation platform used by clinicians to triage and diagnose cardiac conditions from 12-lead and wearable ECGs. Directly competes in the same ECG-as-a-service category as TeqDr, with an EU/UK market presence.
• Eko Health: Eko combines connected stethoscopes and ECG devices with AI-assisted cardiac interpretation for clinicians. Comparable in offering ECG interpretation as a service to medical professionals, particularly via digital/wearable cardiac signals.
• AliveCor: AliveCor (KardiaMobile) is the most direct peer: it provides consumer and clinician-facing ECG devices plus AI-driven ECG interpretation services. Highly comparable to TeqDr's wearable ECG data analysis offering, though operating at significantly larger scale and with FDA-cleared algorithms.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/teqdr
• LinkedInlinkedin.com/company/teqdr

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TeqDr